In Brief: FDA Seeks Cosmetics Comments; L’Oreal/Magic Deal Approved; More
This article was originally published in The Rose Sheet
Executive Summary
FDA will reopen comments for cosmetics regarding its final guidance on Investigational New Drug Applications. China’s Ministry of Commerce approves L’Oreal’s acquisition of Magic Holdings. More.
You may also be interested in...
L’Oreal ‘Surfing’ Makeup Wave To Projected Strong Finish For FY 2016
Acquired brands NYX and Urban Decay are leading growth in L’Oreal’s makeup business, up 15% for the year to date. Strong demand for color cosmetics in the mass and luxury channels drove the firm’s Q3 sales, surpassing analyst expectations, if not L’Oreal’s.
In Brief: Coty Eyes OPI Growth; RevitaLash Is Back; Garnier Pulled From China
Coty aims to drive development of its OPI nail brand in the U.K. with the acquisition of distributor Lena White. More news in brief.
Darzalex Surpasses Stelara As J&J’s Best-Selling Drug
Sales of Stelara are expected to begin tapering off later this year when the first biosimilars launch in mid-2024 in Europe and later in the US.